osimertinibnivolumabdurvalumab
…minantly stereotactic radiosurgery (SRS)) followed by continued osimertinib, with encouraging PFS/OS and acceptable toxicity. By contrast, …
1articles mentioning drugs
2drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: NRG-BR00245 ×
NRG-BR00245
This drug is selected. Its supporting articles are shown below.